发明名称 |
Modulating disease through genetic engineering of plants |
摘要 |
In certain embodiments transgenic plants (e.g., transgenic tomatoes) are provided that comprise cells that express a peptide one or more domains of which comprise the amino acid sequence of an apolipoprotein or apolipoprotein mimetic peptide where the peptide has biological activity (e.g., lowers SAA, and/or increases paroxonase activity, and/or improves HDL inflammatory index, etc.) when the plant and/or the peptide is fed to a mammal. |
申请公布号 |
US9539300(B2) |
申请公布日期 |
2017.01.10 |
申请号 |
US201313789513 |
申请日期 |
2013.03.07 |
申请人 |
The Regents of the University of California |
发明人 |
Fogelman Alan M.;Reddy Srinivasa T.;Navab Mohamad |
分类号 |
A61K38/10;C12N15/63;C07K14/775;A61K36/81;C12N15/82 |
主分类号 |
A61K38/10 |
代理机构 |
Weaver Austin Villeneuve & Sampson LLP |
代理人 |
Hunter Tom;Weaver Austin Villeneuve & Sampson LLP |
主权项 |
1. A transgenic tomato plant comprising cells that express a peptide one or more domains of which comprise the amino acid sequence DWLKAFYDKFFEKFKEFF (SEQ ID NO: 17) wherein said peptide in a fruit of said plant is effective to decrease plasma levels of lysophosphatidic acid (LPA) in a mammal, and/or to decrease serum amyloid A (SAA) levels in said mammal, and/or to increase plasma paraoxonase activity in said mammal when said fruit is fed to said mammal as a lyophilized powder. |
地址 |
Oakland CA US |